Corrigendum to ‘MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes. Urol Oncol 2020:38:738.e9–738.e21’
Jafar Salimian Ph.D. , Behzad Baradaran Ph.D. , Sadegh Azimzadeh Jamalkandi Ph.D. , Abdollah Moridikia M.S. , Ali Ahmadi Ph.D.
{"title":"Corrigendum to ‘MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genes. Urol Oncol 2020:38:738.e9–738.e21’","authors":"Jafar Salimian Ph.D. , Behzad Baradaran Ph.D. , Sadegh Azimzadeh Jamalkandi Ph.D. , Abdollah Moridikia M.S. , Ali Ahmadi Ph.D.","doi":"10.1016/j.urolonc.2024.07.005","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":"42 11","pages":"Pages 376-377"},"PeriodicalIF":2.4000,"publicationDate":"2024-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S107814392400543X/pdfft?md5=b4b978bfdab72afe768e9fe9ad9f1b8d&pid=1-s2.0-S107814392400543X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S107814392400543X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.